WEST TISBURY, Massachusetts – July 01, 2011
Radikal Therapeutics today announced that the Company has been joined by Dr. Rex Gallagher, who will assume the position of Director of Analytical Chemistry. Dr. Gallagher is an experienced bioanalytical mass spectroscopist. He has outstanding experience in natural products research and small molecule drug development in private industry, government, and academia. Dr. Gallagher has worked with cardiac glycosides and natural cardenolides as sodium pump modulators for five years, and anticancer taxanes for over five years. He has specialist knowledge and experience in separations technology and mass spectroscopy. In particular he has over 30 years hands-on experience operating numerous mass spectrometers and setting up analytical laboratories. He has effectively applied expertise in these areas to structure elucidation of a wide array of small molecules, including especially natural products, pharmaceuticals, impurities, contaminants, degradation products and metabolites. He has a number of years experience in in vitro and in vivo metabolism studies, including metabolite ID, CYP450 cross-species comparisons and metabolic pathway elucidation. Dr. Gallagher has managed patent portfolios and patent office actions and is an inventor on 12 patents and author of more than 50 peer-reviewed publications. He has a PhD in Chemistry from Massey University, New Zealand, and was a Fulbright Scholar and Visiting professor to the University of Pennsylvania in 1990.